Lindbrook Capital, LLC Albireo Pharma, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$18.01 - $23.78 $5,222 - $6,896	-290 Reduced 41.08%	416 $0
Q3 2022 Nov 10, 2022	BUY	$16.32 - $26.37 $10,967 - $17,720	672 Added 1976.47%	706 $14,000
Q2 2022 Aug 01, 2022	BUY	$18.54 - $37.29 $278 - $559	15 Added 78.95%	34 $1,000
Q1 2022 Apr 21, 2022	BUY	$23.94 - $33.74 $454 - $641	19 New	19 $1,000
Q3 2020 Nov 03, 2020	SELL	$23.19 - $41.61 $2,597 - $4,660	-112 Closed	0 $0

Q2 2020 Jul 27, 2020	BUY	$14.82 - $29.92 $1,659 - $3,351	112 New	112 $3,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.